IP Verse

Uniqure Biopharma patent opposition analysis

Get complete Patent Opposition Report for Uniqure Biopharma

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest patents of Uniqure Biopharma opposed by its competitors

Explore Uniqure Biopharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP4032979May 1, 2024Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production1
EP3581650Dec 28, 2022Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production1
EP2337849Jun 13, 2018Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production5

Top competitors of Uniqure Biopharma